ATLASImmunoPrecise Antibodies (HYFT) earnings date: Dec 21, 2026
ImmunoPrecise Antibodies (HYFT) reports earnings for the quarter ended Oct 31, 2026 on Mon, Dec 21, 2026. Analysts expect EPS of -$0.05.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on HYFT
| Last price | $1.09 (-4.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.5% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the ImmunoPrecise Antibodies stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
ImmunoPrecise Antibodies reports on Dec 21, 2026. One email the day before, with ATLAS’s read on ImmunoPrecise Antibodies. You can switch it off at any time.
Alert me before HYFT reportsFree to start. Creating an account takes under a minute.
Notify me when ImmunoPrecise Antibodies reports
Track HYFT free Add ImmunoPrecise Antibodies to a free ATLAS watchlist and see its next report date in one place.
HYFT earnings at a glance
| Next report (confirmed) | Mon, Dec 21, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Oct 31, 2026 |
| EPS estimate | -$0.05 |
| Last report | Sep 14, 2026 · Miss |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -19.6% |
| Average move around a report | ±8.3% (last 5) |
| Sector | Healthcare · Biotechnology |
ImmunoPrecise Antibodies earnings history: last 5 reports
ImmunoPrecise Antibodies last reported on Sep 14, 2026: EPS of -$0.09 against an estimate of -$0.05 (-80.0% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Sep 14, 2026 | -$0.05 | -$0.09 | -80.0% | Miss | -11.5% |
| Jul 22, 2026 | -$0.05 | -$0.06 | -20.0% | Miss | -19.2% |
| May 21, 2026 | $2.60 | $3.64 | +40.0% | Beat | +7.6% |
| May 7, 2026 | $4.19 | $4.70 | +12.2% | Beat | 0.0% |
| Mar 12, 2026 | -$0.04 | -$0.06 | -50.0% | Miss | -3.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for HYFT
See the fair value, the probability range and the earnings history of ImmunoPrecise Antibodies on its ATLAS page.
ImmunoPrecise Antibodies (HYFT) stock analysisPlans from €3.99 a month.
ImmunoPrecise Antibodies earnings: frequently asked questions
When does ImmunoPrecise Antibodies (HYFT) report earnings?
ImmunoPrecise Antibodies is scheduled to report on Monday, December 21, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for HYFT?
The consensus EPS estimate for the quarter ended Oct 31, 2026 is -$0.05 per share (USD). Estimates can change before the report.
How often does HYFT beat earnings estimates?
Of its last 5 reports with a recorded result, ImmunoPrecise Antibodies beat the EPS estimate 2 times; the average surprise was -19.6%. Past results do not predict the next one.
How much does HYFT move around earnings?
Over its last 5 reports the stock moved an average of 8.3% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did ImmunoPrecise Antibodies beat earnings estimates last quarter?
ImmunoPrecise Antibodies last reported on Sep 14, 2026: EPS of -$0.09 against an estimate of -$0.05 (-80.0% surprise), a miss.
How much does HYFT usually move in a day?
On a normal trading day the ATLAS model puts HYFT’s one-day range at about ±4.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Dec 21, 2026
Educational information, not investment advice. Disclaimer